Objective To evaluate whether change in fixed-location measures of radiographic joint space width (JSW) and cartilage thickness by MRI predict knee replacement. Methods Knees replaced between 36 and 60 months' followup in the Osteoarthritis Initiative were each matched with one control by age, sex and radiographic status. Radiographic JSW was determined from fixed flexion radiographs and subregional femorotibial cartilage thickness from 3 T MRI. Changes between the annual visit before replacement (T 0 ) and 2 years before T 0 (T -2 ) were compared using conditional logistic regression. Results One hundred and nineteen knees from 102 participants (55.5 % women; age 64.2±8.7 [mean±SD] years) were studied. Fixed-location JSW change at 22.5 % from medial to lateral differed more between replaced and control knees (case-control [cc] OR=1.57; 95 % CI: 1.23-2.01) than minimum medial JSW change (ccOR=1.38; 95 % CI: 1.11-1.71).
Medial femorotibial cartilage loss displayed discrimination similar to minimum JSW, and central tibial cartilage loss similar to fixed-location JSW. Locationindependent thinning and thickening scores were elevated prior to knee replacement. Conclusions Discrimination of structural progression between knee pre-placement cases versus controls was stronger for fixed-location than minimum radiographic JSW. MRI displayed similar discrimination to radiography and suggested greater simultaneous cartilage thickening and loss prior to knee replacement. Key Points • Fixed-location JSW predicts surgical knee replacement more strongly than minimum JSW.
• MRI predicts knee replacement with similar accuracy to radiographic JSW.
• MRI reveals greater cartilage thinning and thickening prior to knee replacement.
Introduction
Osteoarthritis is the most common form of arthritis, with the knee most commonly affected. The lifetime risk of knee osteoarthritis is 14 %, and almost 10 % of the US population has a diagnosis of knee osteoarthritis by the age of 60 years [1] . Knee osteoarthritis substantially impacts the remaining qualityadjusted life-years of persons aged 50-84 years [2] . Patients with knee osteoarthritis show elevated utilization of health care including diagnostic imaging, with much of the expense for therapy being the result of knee replacement surgery. The number of knees replaced in the USA has doubled over the last decade, and over half the patients diagnosed with knee osteoarthritis eventually undergo knee replacement [3] . Currently, no structure-modifying agent has been approved for the treatment of osteoarthritis. Radiological imaging represents the most direct way of evaluating structural progression, with conventional radiography and magnetic resonance imaging (MRI) being most often utilized [4, 5] . Regulatory guidance for approval of disease-modifying osteoarthritis drugs (DMOADs) requests a reduction in structural pathology to be accompanied by benefits in clinical outcomes. Ideally, radiological imaging biomarkers used in clinical trials should thus not only reliably indicate structural progression, but also predict relevant clinical outcomes such as knee replacement [5, 6] .
Reduction in radiographic joint space width (JSW) is recognized as the standard for demonstrating structural benefits in knee osteoarthritis by the US Food and Drug Administration (FDA) and other regulatory bodies. A minimum JSW was shown to predict joint replacement in the hip [7] and knee [8, 9] . However, 'fixed-location measures' of femorotibial JSW were recently demonstrated to be more sensitive in detecting structural change in knee osteoarthritis than minimum JSW [10, 11] ; fixed-location measures have not, however, been related to the risk of knee replacement.
Quantitative measures of cartilage loss by MRI were shown to be more sensitive to change than radiographs [5, 6] and to predict knee replacement [6, [12] [13] [14] , in particular in 'fast clinical progressors' with less advanced radiographic disease stages at baseline [14, 15] . However, only a small study compared MRI with radiography in the context of predicting knee replacement and relied on an outdated radiographic acquisition method [16] . Finally, recent work using MRI highlighted that spatial patterns of femorotibial cartilage loss vary substantially between subjects, depending on individual sets of risk factors [17, 18] . MRI has been used to determine the (maximum) rate of cartilage loss, independent of spatial location [18, 19] , by ordering the rates of subregional femorotibial cartilage thickness change according to magnitude in each knee. This approach was shown to be more sensitive in discriminating rates of cartilage loss between radiographic strata [18, 19] , but it has not been studied to what extent these location-independent approaches are related to knee replacement.
The purpose of this study was therefore to evaluate with what level of accuracy fixed-location measures of radiographic JSW, region-specific MRI and location-independent MRI predict knee replacement as a clinical outcome, compared with minimum radiographic JSW.
Methods

Study design
This case-control study is ancillary to the Osteoarthritis Initiative (OAI), an ongoing prospective, multicentre cohort study (http://www.oai.ucsf.edu/) designed to identify and validate imaging, biochemical and genetic biomarkers for the onset and/or progression of knee osteoarthritis. The Osteoarthritis Initiative was conducted in compliance with the ethical principles derived from the Declaration of Helsinki, in compliance with the local Institutional Review Board, informed consent regulations and International Conference on Harmonization Good Clinical Practices Guidelines. The OAI, its imaging protocol and quality assurance metrics over 8 years have been reported previously [20] [21] [22] Tesla (3T) MRI at baseline and at 12-, 24-, 36-and 48-month follow-up (M) [21] . There was also a clinical visit, without imaging, at 60 months. Participants were interviewed about having received a knee replacement in the preceding year and this was confirmed by radiography or from hospital records when the former was not available.
The sample studied here, i.e. the OAI participants who received a knee replacement, and one control for each of them (Fig. 1) , was described previously, with the 2-year observation interval of MRI-based cartilage loss prior to knee replacement (T -2 →T 0 ) being most discriminative between cases and controls [15] . To be eligible as a case, a knee replacement had to be confirmed at 36, 48 or 60 months and fixed flexion X-rays acceptable for radiographic JSW analysis and MRI acquisitions had to be available for T -2 and T 0 . When both knees of one participant were replaced, both were included. Control knees were selected from OAI participants without knee replacement between baseline and 60 months (Fig. 1) . If the contralateral knee received a knee replacement during the study, knees did not qualify as controls. Controls had to have fixed flexion radiographs and MRIs available at time points corresponding to those of knees replaced (T -2 and T 0 ), and were matched 1:1 to the cases by sex, age (±5 years) and radiographic disease stage (Fig. 1) . The matching for radiographic disease stage was done by using release 0.4 from the OAI, i.e. the central readings by three expert radiologists or rheumatologists at Boston University (https://oai.epiucsf.org/datarelease/SASDocs/kXR_ SQ_BU_descrip.pdf) at the baseline visit. These readings used the traditional KLG classification as well as Osteoarthritis Research Society International (OARSI) osteophyte and joint space narrowing (JSN) scores. The matching was performed using the following KLG strata: 0-2, 3 or 4. In a second (post-hoc) step, only casecontrol pairs were included in whom the same compartment (medial or lateral or both) showed evidence of radiographic JSN.
Radiography
The radiographic JSW measurement relied on fixed flexion radiographs acquired using a SynaFlexer™ frame (Bioclinica, Newtown, PA, USA) [21] . Minimum and fixed-location JSW measures in the medial femorotibial compartment were performed by one of the authors (J.D.) using automated software [10, 23] (Fig. 2a) . The software determines a line tangential to the femoral condyles to represent the x-axis of the coordinate system. The medial and lateral borders of the knee are then marked manually, tangential to the largest prominence of the femoral epicondyles to determine location-specific positions in the joint from 0.0 (0 %) to 1.0 (100 %) (Fig. 2a) . Medial compartment fixed-location JSW(x) measurements were obtained between 0.15 (15 %) and 0.30 (30 %) in the medial femorotibial compartment. The radiographs were read viewing all time points (including visits other than T 0 and T -2 ) simultaneously but with the reader blinded to the correct order. 
Region-specific magnetic resonance imaging (MRI)
MRI analysis relied on the oblique sagittal double-echo steady-state (DESS) sequence with water excitation [21] ( Fig. 2b) . Segmentation of the femorotibial cartilages was performed at one centre (Chondrometrics GmbH, Ainring, Germany). T -2 and T 0 images were processed as pairs by one of 12 readers, but with blinding to case/ control status and to image acquisition order [15] . All segmentations were quality controlled by one of two experts (S.M. and F.E). The mean cartilage thickness (ThCtAB.Me) was computed in the medial and in the lateral femorotibial compartment, and in five tibial (central, external, internal, anterior and posterior) and three medial and lateral femoral subregions (central, external and internal) [24] (Fig. 2c ). Cartilage thickness change was computed as an absolute value (μm).
Location-independent MRI
Based on the above 16 subregions, location-independent cartilage thickness change was determined using the extended ordered value (OV) approach [19] : Ordered value 1 represented the subregion with the greatest rate of cartilage thinning in each knee, ordered value 2 the subregion with the second strongest thinning, and so forth, up to ordered value 16, the subregion with the least thinning or with the greatest rate of thickening [19] . In addition, novel summary measures of subregional cartilage thickness change were computed [25] ; these included the total subregional cartilage thinning score, i.e. the sum of all negative cartilage thickness changes across as many of the 16 subregions in which cartilage loss occurred in each knee, the total subregional cartilage thickening score (the sum of all positive cartilage thickness changes), and the total subregional cartilage change score (the sum or all 16 subregional cartilage thickness changes independent of direction).
Statistical analysis
All tests were performed using SAS software (version 9.2, SAS Institute, Cary, NC, USA). Minimum radiographic JSW (mJSW) in the medial compartment was considered the benchmark structural outcome, because it represents the accepted imaging endpoint in context of structure modification in knee osteoarthritis. Fixed location JSW at 22.5 % from the medial to lateral edge of the femoral condyle (x=0.225, Fig. 2a ) was used as the comparative radiographic measure because it was previously found to be the most responsive location in knee osteoarthritis-related JSW change [10, 11] . Medial femorotibial compartment cartilage thickness change was used as a global measure of region-specific MRI analysis ( Fig. 2b) , because it summarizes change across the entire medial femorotibial compartment. Central medial tibial (cMT) cartilage thickness was used as a subregional measure, because it was previously identified as most discriminative between knees replaced and matched controls [14] (Fig. 2c ). Extended OVs [19] and total subregional thinning, thickening and change scores were used as location-independent MRI measures of cartilage change. Raw differences between the rates of change in knees replaced and non-replaced controls were compared using paired t-tests (Fig. 1) . After standardizing the variables to facilitate comparisons, casecontrol conditional logistic regression odds ratios (ccOR) were calculated using generalized estimating equation models with an independent working correlation and a robust sandwich estimator to account for the correlation of knees within an individual [14, 15] . Robustness of these comparisons was evaluated by adjusting for the effects of baseline body mass index (BMI) and pain at T -2 (ccOR bp ) [15] since previous studies have revealed associations of cartilage loss with BMI and pain [26, 27] . No adjustment for multiple comparisons was made, because the study was exploratory and because measures are expected to be highly correlated to each other. Given previous observations of superior discrimination between case/control pairs with 'early' radiographic disease status at baseline [14, 15] , sensitivity analyses were conducted using a stratum of KLG0-2 knees, and further sensitivity analyses were performed excluding case/control pairs with a mismatch in the location (medial/lateral) of baseline JSN.
Results
Sample description
One hundred and sixty-two knees of 139 OAI participants received a femorotibial knee replacement between 36 and 60 months ( Fig. 1 Fig. 3 ). Change in fixed-location JSW at 22.5 % from medial to lateral (x=0.225) also differed strongly and significantly between matched case-control pairs (p=0.0001) and displayed greater ORs than minimum JSW (ccOR=1.57, cc pb OR=1.64; Table 1 , Fig. 3 ).
MRI
MRI cartilage loss in the medial femorotibial compartment displayed similar discrimination between knees replaced and non-replaced controls (paired t-test p=0.001
and ccOR = 1.38) as did minimum JSW (Table 1 , Fig. 3 ). Central tibial cartilage loss showed higher odds ratios than the entire medial femorotibial compartment (p<0.0001 and ccOR=1.57), and similar discrimination to fixed-location JSW (Table 1, Fig. 3 ).
As location-independent measures, OV1-OV10 discriminated significantly between matched pairs (range p=0.02 to p<0.0001), with greater cartilage loss observed in cases with knee replacement than in non-replaced controls, and with the greatest ccOR observed for OV2 (1.57; Table 1 ). OV13-16 suggested slightly greater subregional cartilage thickening in knee replacements than in controls, but the difference only Values are in μm SD standard deviation, CI confidence interval, ccOR case-control conditional logistic regression odds ratios adjusting for matching variables and bilateral knees, ccOR bp ccOR adjusting for the above and additionally for the effects of BMI and pain at baseline (T -2 ), mJSW minimum joint space width in the medial femorotibial compartment, measured using fixed flexion radiographs, JSW225 joint space width measured at a fixed location (22.5 % from medial to lateral) in the medial femorotibial compartment, measured using fixed flexion radiographs, MFTC total medial femorotibial compartment cartilage loss, as measured quantitative by MRI, cMT central medial tibial cartilage loss, as measured quantitative by MRI, OV ordered values cartilage loss throughout 16 femorotibial subregions, sorted individually by magnitude (i.e. 1-16), Thinn. Score total subregional thinning score sum of all negative cartilage thickness changes across as many of the 16 subregions in which cartilage loss occurred in each knee, Thick. Score total subregional cartilage thickening score the sum of all positive cartilage thickness changes, Change Score total subregional cartilage change score sum or all 16 subregional cartilage thickness changes, independent of direction reached significance for OV16 (p=0.02; ccOR=0.76). The total subregional thinning score was greater in knee replacements than in controls (p<0.0001; ccOR=1.48), whereas the difference in the total thickening score failed to reach statistical significance (Table 1, Fig. 3 ). The total subregional change score discriminated significantly between case-control pairs (p<0.0001; ccOR=0.65).
Sensitivity analyses
When restricting analysis to case-control pairs with less advanced radiographic disease stage at baseline (KLG0-2), the ORs for all imaging measures were greater than for the full sample; however, the relative performance of these measures was similar (Table 2 ). However, cartilage loss appeared to dominate in this group of 'fast clinical progressors', as subregional cartilage thickening (OVs 13-16, and total subregional thickening score) was less in knees replaced than in matched controls (Table 2) . When restricting analysis to the 70 case control pairs in which the location of the baseline JSN was observed in the same (medial or lateral) compartment, both the ORs and the relative performance of the measures were similar to the full sample (Table 3) . However, when accounting for JSN location, subregional thickening was found to be significantly greater in OV 14-16 of knees replaced than in non-replaced controls, despite the smaller sample (Table 3) .
Discussion
In this study we have explored for the first time the relative performance of fixed-location and minimum radiographic JSW, and that of region-specific and location-independent MRI measures of cartilage thickness change, in predicting femorotibial knee replacement as a clinical outcome. The reliability of the fixed-location measurements [23] and that of subregional MRI measurements has been described previously [24] , and a face-to-face comparison of their responsiveness (i.e. sensitivity to change in knee osteoarthritis) has also been presented [11] . Change in fixed-location radiographic JSW differed more between knees replaced and non-replaced controls than that in minimum medial JSW, a measure recognized as a structural endpoint for DMOAD intervention trials by regulatory agencies. The 'feasibility' of both measurements (fixed-location radiographic JSW measurement and minimum JSW measurement) is very similar, since they are both based on the delineated joint margins from the same automated measurement technique [23] using the very same radiographic acquisition. Since the 'responsiveness' of fixedlocation JSW in knee osteoarthritis has previously been shown to be greater than that of minimum JSW [11] , the current results suggest that fixed-location measurements of radiographic JSW are superior to minimum JSW and should preferably be used in future studies. MRI measurement of central tibial cartilage thickness change showed similar discrimination between knee replacements and controls to fixedlocation JSW. Location-independent measures of femorotibial cartilage change suggested 'perturbation' of cartilage thickness prior to knee replacement, with greater rates of subregional thickening and loss occurring simultaneously than in non-replaced controls.
Despite the great clinical success of knee replacement, the criteria on which surgery is performed are not uniform. Apart from symptom and radiographic status, surgical indication depends on willingness, co-morbidity, access to health care, socio-economic status, etc. Yet, knee replacement represents a 'hard' outcome and a socioeconomic reality and thus a clinical endpoint against which an imaging biomarker and the effect of DMOADs should be evaluated [6, 14] .
A limitation of the current study is that, albeit controls did not undergo knee replacement up to 60 months, they may have been replaced later. Also, controls may have been in need for knee replacement, but did not receive it for reasons mentioned above. Future studies that may use a validated 'virtual' knee replacement (vTKR) indication as a clinical outcome may circumvent such classification issues and potentially improve the discrimination between cases and controls. Further, the current study focused on quantitative measures of radiographic change and cartilage loss, while a recent study examined the ability of other features of structural pathology for predicting knee replacement [28] .
Only one prior study compared radiographic JSW and cartilage volume change with respect to clinical outcome [16] . The authors showed a trend towards a significant relationship between 2-year change in medial femorotibial compartment volume and knee replacement at year 4 (OR=9.0, p=0.07), but no relationship for minimum JSW change (OR=1.1, p= 0.92). In that study, however, radiographs were acquired in full knee extension. Furthermore, only 28 of 113 subjects had radiographs taken with sufficient quality to support JSW measures, with the statistical analysis based on five knees with replacement [16] . Our current results contradict the above Values are in μm SD standard deviation, CI confidence interval, ccOR case-control conditional logistic regression odds ratios adjusting for matching variables and bilateral knees, ccOR bp ccOR adjusting for the above and additionally for the effects of BMI and pain at baseline (T -2 ), mJSW minimum joint space width in the medial femorotibial compartment, measured using fixed flexion radiographs, JSW225 joint space width measured at a fixed location (22.5 % from medial to lateral) in the medial femorotibial compartment, measured using fixed flexion radiographs, MFTC total medial femorotibial compartment cartilage loss, as measured quantitative by MRI, cMT central medial tibial cartilage loss, as measured quantitative by MRI, OV ordered values cartilage loss throughout 16 femorotibial subregions, sorted individually by magnitude (i.e. 1-16), Thinn. Score total subregional thinning score sum of all negative cartilage thickness changes across as many of the 16 subregions in which cartilage loss occurred in each knee, Thick. Score total subregional cartilage thickening score the sum of all positive cartilage thickness changes, Change Score total subregional cartilage change score sum or all 16 subregional cartilage thickness changes, independent of direction findings in that, when fixed flexion radiographs are used, radiographic JSW appears to discriminate similarly between knees replaced and non-replaced controls as MRI-based cartilage thickness measures. Furthermore, fixed-location measurements appeared to be superior to minimum JSW. The ORs observed in the current study are smaller than those reported above [16] , and than those in another study (113 participants, 18 with knee replacement) focusing on MRI cartilage volume change alone [12] . However, in the current study cases and controls were matched for age, sex and for baseline radiographic status (KLG): Since knees with advanced radiographic knee osteoarthritis exhibit substantially larger rates of cartilage loss than those at an earlier stage [19] and also are more likely to receive knee replacement in the intermediate future, it is obvious that ORs are substantially lower using the matched case-control design, since they reflect the differences observed 'over and above' radiographic baseline status rather than the total difference between knees in case cohort studies.
Studying knee radiographs acquired in full extension, Bruyere et al. [8] reported cut-offs of 0.5-0.8 mm in minimum JSW change over 3 years to discriminate between knees that received a knee replacement up to 8 years' follow-up (n=16) versus those who did not. Change in mean JSW, in contrast, Values are in μm SD standard deviation, CI confidence interval, ccOR case-control conditional logistic regression odds ratios adjusting for matching variables and bilateral knees, ccOR bp ccOR adjusting for the above and additionally for the effects of BMI and pain at baseline (T -2 ), mJSW minimum joint space width in the medial femorotibial compartment, measured using fixed flexion radiographs, JSW225 joint space width measured at a fixed location (22.5 % from medial to lateral) in the medial femorotibial compartment, measured using fixed flexion radiographs, MFTC total medial femorotibial compartment cartilage loss, as measured quantitative by MRI, cMT central medial tibial cartilage loss, as measured quantitative by MRI, OV ordered values cartilage loss throughout 16 femorotibial subregions, sorted individually by magnitude (i.e. 1-16), Thinn. Score total subregional thinning score sum of all negative cartilage thickness changes across as many of the 16 subregions in which cartilage loss occurred in each knee, Thick. Score total subregional cartilage thickening score the sum of all positive cartilage thickness changes, Change Score total subregional cartilage change score sum or all 16 subregional cartilage thickness changes, independent of direction was not predictive of knee replacement [8] . Our current study extend these findings in several important ways: it used a nested matched case-control study design, confirming that differences in change in minimum JSW exist between knees replaced and controls, even after matching for baseline KLG status; it studied a non-fluoroscopic radiographic acquisition technique now commonly used in clinical trials; its results suggest that with fixed-flexion radiography, fixed-location JSW change at 22.5 % from medial to lateral (x=0.225) is superior in discriminating between knees replaced versus matched controls than minimum JSW; and it showed that medial cartilage loss by MRI has a similar ability to predict knee replacement as a clinical outcome to the radiographic measures currently accepted for disease modification by regulatory agencies. The latter finding is important, because radiographs are generally part of the decision making in an indication to knee replacement surgery, whereas quantitative MRI cartilage loss represents an independent measure. Location-independent MRI-based measures of femorotibial cartilage thickness change, including OVs and novel sum scores, appear to exhibit a similar ability to discriminate between knees replaced and controls as the most discriminative region-/location-specific MRI (cMT) and radiographic measure (JSW at x = 0.225). Although apparently not superior in predicting knee replacement, these measures were shown to be statistically superior in discriminating rates of cartilage loss between radiographic strata [18, 19] than region-specific approaches of MRI-based cartilage loss and radiographic JSW change. Furthermore, these location-independent measures preclude the need to define a specific cartilage region of interest a priori, tailored to the study inclusion criteria such as medial or lateral compartment involvement, and they can help to assess subregional cartilage thickness change in either direction (loss or swelling) independently. The current study provides evidence that not only cartilage loss but also subregional thickness gain was greater over 2 years prior to knee replacement than in matched controls. Greater simultaneous subregional cartilage thickness gain and loss also have been recently reported after anterior cruciate ligament injury [25] and may describe a state of cartilage 'perturbation', during which cartilage loss in some locations is accompanied by cartilage swelling or hypertrophy in others. Such observations are unique to the use of locationindependent MRI and are obscured when only region-specific measurements are performed by MRI or radiography [25] .
In conclusion, discrimination of structural progression rates between knees replaced versus controls was greater for fixed-location radiographic JSW than for minimum medial JSW. MRI-measures of cartilage thickness change displayed similar discrimination between knee replacements and non-replaced controls to radiography, and suggested 'perturbation' of cartilage thickness prior to knee replacement, with greater rates of subregional thickening and loss occurring simultaneously than in non-replaced controls. Drugs that attempt to modify the structural changes that lead to knee replacement may thus have to stabilize cartilage by preventing both cartilage loss and cartilage thickening due to swelling or hypertrophy.
